HIV/AIDS Activists Give Harsh Grades to Drug Companies

36:12
 
공유
 

Manage episode 127201 series 2246
Player FM과 저희 커뮤니티의 TheBody.com: Podcast Central 콘텐츠는 모두 원 저작자에게 속하며 Player FM이 아닌 작가가 저작권을 갖습니다. 오디오는 해당 서버에서 직접 스트리밍 됩니다. 구독 버튼을 눌러 Player FM에서 업데이트 현황을 확인하세요. 혹은 다른 팟캐스트 앱에서 URL을 불러오세요.
Abbott Laboratories: F. Hoffman-La Roche Ltd.: D. Boehringer Ingelheim: D+. If the nine major HIV drug companies were in school, most would probably be in detention, according to a new "report card" issued by the AIDS Treatment Activists Coalition (ATAC). ATAC graded the drug companies in five different categories, including fair pricing and their relationship with the HIV community. Some did alright -- Merck & Co. and Tibotec Therapeutics both got B's -- but most didn't fare as well. In this one-on-one interview, we get the nitty-gritty on this telling report from longtime HIV/AIDS journalist and activist Bob Huff, a member of ATAC's board of directors.

77 에피소드